Skip to main navigation Skip to search Skip to main content

The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation

  • C.T. Collins
  • , R.A. Gibson
  • , M. Makrides
  • , A.J. Mcphee
  • , T.R. Sullivan
  • , P.G. Davis
  • , M. Thio
  • , Karen Simmer
  • , V.S. Rajadurai
  • , P. Ryan
  • , S. Morris
  • , M. Stark
  • , J. Travadi
  • , I. Wright
  • , K. Tan
  • , J. Holberton
  • , G. Opie
  • , I. Callander
  • , J. Stack
  • , D. Shein
    • S. Bellhouse, S. Bolisetty, K. Lui, H. Liley, M. Berry, D. Harris, M.C. Chua, P. Agarwal

    Research output: Contribution to journal › Article › peer-review

    29   Link opens in a new tab Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry